Will CRISPR’s promise force the organic industry to reconsider its opposition to gene-edited crops?

ANDREW PORTERFIELD | November 13, 2019

article image
Opposition to genetically modified (GM) crops advanced by organic activist groups (and official organizations like the US National Organic Standards Board (NOSB) or the EU’s European Court of Justice) is based on the claim that recombinant DNA technology introduces genes from one species into another. That’s not natural, these critics contend. By this definition, though, gene-editing techniques like CRISPR/Cas9 are natural: They’re part of the immune system in many species of bacteria. Scientists are now using these tools to make specific changes (or edits) to the DNA of food crops and animals to boost their nutritional content or protect them from disease, without adding “foreign” genes to their genomes.

Spotlight

Sheridan Healthcare

Sheridan Healthcare, the Envision Healthcare solution for anesthesia provider services, is the leader in provider of anesthesiology management solutions to physicians, hospitals and outpatient centers. Our dedication to collaboration, leadership and quality provides our hospitals and patients with the attention they deserve. Physician led and managed, we employ the highest-quality health providers and offer them competitive benefits, training opportunities, and flexible work schedules.

OTHER ARTICLES
MEDICAL

Better Purification and Recovery in Bioprocessing

Article | August 2, 2021

In the downstream portion of any bioprocess, one must pick through the dross before one can seize the gold the biotherapeutic that the bioprocess was always meant to generate. Unfortunately, the dross is both voluminous and various. And the biotherapeutic gold, unlike real gold, is corruptible. That is, it can suffer structural damage and activity loss. When discarding the dross and collecting the gold, bioprocessors must be efficient and gentle. They must, to the extent possible, eliminate contaminants and organic debris while ensuring that biotherapeutics avoid aggregation-inducing stresses and retain their integrity during purification and recovery. Anything less compromises purity and reduces yield. To purify and recover biotherapeutics efficiently and gently, bioprocessors must avail themselves of the most appropriate tools and techniques. Here, we talk with several experts about which tools and techniques can help bioprocessors overcome persistent challenges. Some of these experts also touch on new approaches that can help bioprocessors address emerging challenges.

Read More
DIAGNOSTICS

Making Predictions by Digitizing Bioprocessing

Article | April 20, 2021

With advances in data analytics and machine learning, the move from descriptive and diagnostic analytics to predictive and prescriptive analytics and controls—allowing us to better forecast and understand what will happen and thus optimize process outcomes—is not only feasible but inevitable, according to Bonnie Shum, principal engineer, pharma technical innovation, technology & manufacturing sciences and technology at Genentech. “Well-trained artificial intelligence systems can help drive better decision making and how data is analyzed from drug discovery to process development and to manufacturing processes,” she says. Those advances, though, only really matter when they improve the lives of patients. That’s exactly what Shum expects. “The convergence of digital transformation and operational/processing changes will be critical for the facilities of the future and meeting the needs of our patients,” she continues. “Digital solutions may one day provide fully automated bioprocessing, eliminating manual intervention and enabling us to anticipate potential process deviations to prevent process failures, leading to real-time release and thus faster access for patients.” To turn Bioprocessing 4.0 into a production line for precision healthcare, real-time release and quickly manufacturing personalized medicines will be critical. Adding digitization and advanced analytics wherever possible will drive those improvements. In fact, many of these improvements, especially moving from descriptive to predictive bioprocessing, depend on more digitization.

Read More

Spotlight

Sheridan Healthcare

Sheridan Healthcare, the Envision Healthcare solution for anesthesia provider services, is the leader in provider of anesthesiology management solutions to physicians, hospitals and outpatient centers. Our dedication to collaboration, leadership and quality provides our hospitals and patients with the attention they deserve. Physician led and managed, we employ the highest-quality health providers and offer them competitive benefits, training opportunities, and flexible work schedules.

Events